|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7645 USD | -5.95% |
|
+2.80% | -62.52% |
| Apr. 15 | Nature Medicine Publishes Interim Results from Gritstone Bio's Phase 1/2 Study of "Off-The-Shelf" Neoantigen Vaccine Platform | CI |
| Apr. 02 | Top Midday Decliners | MT |
Aug 17 (Reuters) - Gritstone bio Inc said on Tuesday it had entered into a funding agreement of up to $20.6 million with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance its COVID-19 vaccine program against coronavirus variants. (Reporting by Dania Nadeem in Bengaluru)
| 1st Jan change | Capi. | |
|---|---|---|
| -62.52% | 86.49M | |
| -4.22% | 87.31B | |
| +2.63% | 40.86B | |
| -21.76% | 29.36B | |
| +58.56% | 24.49B | |
| -14.78% | 17.31B | |
| -18.49% | 11.62B | |
| -15.61% | 11.31B | |
| -44.02% | 11.26B | |
| +5.17% | 8.31B |
GRITSTONE BIO, INC. 
